Document is current
Any future updates will be listed below
-
Authors
Kovalchik, Kevin A. https://orcid.org/0000-0002-2541-7721
Hamelin, David J.
Kubiniok, Peter https://orcid.org/0000-0001-8244-143X
Bourdin, Benoîte
Mostefai, Fatima https://orcid.org/0000-0001-5280-5220
Poujol, Raphaël
Paré, Bastien
Simpson, Shawn M.
Sidney, John
Bonneil, Éric https://orcid.org/0000-0002-4039-3131
Courcelles, Mathieu https://orcid.org/0000-0001-5961-8858
Saini, Sunil Kumar https://orcid.org/0000-0003-3382-9432
Shahbazy, Mohammad https://orcid.org/0000-0003-2684-3092
Kapoor, Saketh
Rajesh, Vigneshwar https://orcid.org/0000-0001-7436-6943
Weitzen, Maya https://orcid.org/0009-0000-9170-1846
Grenier, Jean-Christophe
Gharsallaoui, Bayrem
Maréchal, Loïze
Wu, Zhaoguan
Savoie, Christopher https://orcid.org/0000-0002-4910-3225
Sette, Alessandro https://orcid.org/0000-0001-7013-2250
Thibault, Pierre https://orcid.org/0000-0001-5993-0331
Sirois, Isabelle https://orcid.org/0000-0002-6929-1761
Smith, Martin A. https://orcid.org/0000-0003-2259-1713
Decaluwe, Hélène https://orcid.org/0000-0001-6617-0633
Hussin, Julie G. https://orcid.org/0000-0003-4295-3339
Lavallée-Adam, Mathieu https://orcid.org/0000-0003-2124-3872
Caron, Etienne https://orcid.org/0000-0003-2770-6970
- License Information
-
More Information
Article History
Received: 31 January 2024
Accepted: 20 November 2024
First Online: 28 November 2024
Competing interests
: E.C. and I.S. are co-founders of Neomabs Biotechnologies Inc. PT is a co-founder of Epitopea. A.S. is a consultant for Alcimed, Gritstone, Darwin Health, EmerVax, Gilead Sciences, Guggenheim Securities, Link University, RiverVest Venture Partners, and Arcturus. La Jolla Institute for Immunology has filed for patent protection for various aspects of T cell epitope and vaccine design work. All other authors declare no competing interests.
: This research prioritizes inclusivity by engaging diverse populations, particularly underrepresented groups. All participants provided informed consent, and their confidentiality was safeguarded in accordance with ethical guidelines. The contributions of all team members were acknowledged, and potential biases were actively addressed. We aim to conduct research that advances knowledge while respecting the rights and dignity of all individuals involved.
